Aptar Pharma

With the new facility, Aptar aims to meet the region’s growing needs by adding 4400 m2 of manufacturing footprint

The formulation provides a physical barrier on nasal mucosa that could prevent and/or trap viral particles and aid in the defence…

Armed with big data, healthcare organisations and policymakers can make necessary changes that will help patients around the…

Gives an insight about the global dermal market, and how their solutions could be applied to the Chinese market in a changing…

Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech,…

To provide delivery system and regulatory support for Narcan, a needle-free, ready-to use medication, which can stop or reverse…

The patented eDose Counter for MDIs has been designed to be easy-to-use and reliable, and contributes to patient compliance

They are designed for sensitive and high-value injectables

Date: May 5-8, 2015 Venue: Antibes, France